FDA approves extended-release, single-entity hydrocodone product with abuse-deterrent properties

The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Hysingla ER has approved labeling describing the product’s abuse-deterrent properties consistentwith the FDA’s 2013 draft guidance for industry, Abuse-Deterrent Opioids – Evaluation and Labeling.
Hysingla ER has properties that are expected to reduce, but not totally prevent, abuse of the drug when chewed and then taken orally, or crushed and snorted or injected. The tablet is difficult to crush, break or dissolve. It also forms a viscous hydrogel (thick gel) and cannot be easily prepared for injection. The FDA has determined that the physical and chemical properties of Hysingla ER are expected to make abuse by these routes difficult. However, abuse of Hysingla ER by these routes is still possible. It is important to note that taking too much Hysingla ER, whether by intentional abuse or by accident, can cause an overdose that may result in death.
Hysingla ER is not approved for, and should not be used for, as-needed pain relief. Given Hysingla ER’s risks for abuse, misuse and addiction, it should only be prescribed to people for whom alternative treatment options are ineffective, not tolerated or would be otherwise inadequate to provide sufficient pain management. As a single-entity opioid, Hysingla ER does not carry the serious liver toxicity risks associated with hydrocodone combination products containing acetaminophen. The FDA encourages health care professionals to review and consider all available information as part of their decision-making when prescribing opioid analgesics.
Strengths of Hysingla ER contain 20, 30, 40, 60, 80, 100 and 120 milligrams (mg) of hydrocodone to be taken every 24 hours. Doses of 80 mg per day and higher should not be prescribed to people who have not previously taken an opioid medication (opioid non-tolerant). While Hysingla ER contains larger amounts of hydrocodone compared to immediate-release hydrocodone combination products, the range of tablet strengths of Hysingla ER is comparable to existing approved ER opioids. 
For more information on the Approval CLICK HERE

1 comment:


  1. kurupt moonrock
    jack herrer pipe
    cherry pie strain price


    Tavor 7 For Sale
    Tavor 7

    Tavor 7 For Sale. The TAVOR 7 is a fully ambidextrous platform on which the ejection side and the charging handle can be switched quickly and easily from side ...

    Uzi Pro 9mm Pistol
    Tavor ts12 for sale




    Bird and Parrot Store is the largest live bird breeder and seller. We also sell bird food, bird toys, accessories and everything you need for your birds. Parakeets for Sale, Caiques for sale, Eclectus for sale, Cockatoos for sale, Conures for Sale, Amazons Parrots For sale, African Grey Parrots for Sale, Macaws for sale, LoveBirds for Sale, Senegal Parrots For Sale, Softbills For Sale, Toucans, and Touracos for Sale, Poicephalus for Sale, Pionus for Sale, Lories, and Lorikeets for Sale, Parrotlets for Sale. Bird Breeders Store

    ReplyDelete